Accurate assessment of beta-cell function: the hyperbolic correction - PubMed (original) (raw)
Review
Accurate assessment of beta-cell function: the hyperbolic correction
Richard N Bergman et al. Diabetes. 2002 Feb.
Abstract
Only in the last decade did modeling studies predict, and knockout experiments confirm, that type 2 diabetes is a "2-hit" disease in which insulin resistance is necessarily accompanied by beta-cell defect(s) preventing the compensatory upregulation of insulin secretion. This long- delayed insight was associated with the development of a constant, the "disposition index," describing the beta-cell sensitivity-secretion relationship as a rectangular hyperbola. Shifts in insulin sensitivity are accompanied by compensatory alterations in beta-cell sensitivity to glucose. Insulin-sensitive subjects do not require a massive insulin response to exogenous glucose to maintain a normal blood glucose. But if their insulin sensitivity decreases by 80%, as in late pregnancy, they need a fivefold greater insulin response to achieve an identical disposition index. Women with gestational diabetes have an insulin response similar to that of normal volunteers; at first glance, this suggests similar islet function, but the utility of the disposition index is to normalize this response to the amplitude of third trimester insulin resistance, revealing severe beta-cell deficiency. The index is a quantitative, convenient, and accurate tool in analyzing epidemiologic data and identifying incipient impaired glucose tolerance. Separate major issues remain, however: the causes of insulin resistance, the causes of the failure of adequate beta-cell compensation in type 2 diabetes, and the nature of the signal(s) from insulin-resistant tissues that fail to elicit the appropriate beta-cell increment in sensitivity to glucose and other stimuli. The disposition index is likely to remain the most accurate physiologic measure for testing hypotheses and solutions to these challenges in whole organisms.
Similar articles
- Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.
Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B. Retnakaran R, et al. Diabetologia. 2005 May;48(5):993-1001. doi: 10.1007/s00125-005-1710-x. Epub 2005 Mar 19. Diabetologia. 2005. PMID: 15778860 - [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
Zeng CJ, Zhang L, Yang HX. Zeng CJ, et al. Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):658-63. Zhonghua Fu Chan Ke Za Zhi. 2010. PMID: 21092544 Chinese. - Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.
Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, Goico J, Ochoa C, Azen SP. Buchanan TA, et al. Diabetes. 2000 May;49(5):782-8. doi: 10.2337/diabetes.49.5.782. Diabetes. 2000. PMID: 10905487 Clinical Trial. - Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.
Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr. Kahn SE, et al. J Nutr. 2001 Feb;131(2):354S-60S. doi: 10.1093/jn/131.2.354S. J Nutr. 2001. PMID: 11160560 Review. - Banting lecture 1990. Beta-cells in type II diabetes mellitus.
Porte D Jr. Porte D Jr. Diabetes. 1991 Feb;40(2):166-80. doi: 10.2337/diab.40.2.166. Diabetes. 1991. PMID: 1991568 Review.
Cited by
- Beta-cell preservation…Is weight loss the answer?
Mazza AD, Pratley RE, Smith SR. Mazza AD, et al. Rev Diabet Stud. 2011 Winter;8(4):446-53. doi: 10.1900/RDS.2011.8.446. Epub 2012 Feb 10. Rev Diabet Stud. 2011. PMID: 22580726 Free PMC article. Review. - Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome.
Norris JM, Rich SS. Norris JM, et al. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2091-6. doi: 10.1161/ATVBAHA.112.255463. Arterioscler Thromb Vasc Biol. 2012. PMID: 22895670 Free PMC article. Review. - Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance.
Bergman RN. Bergman RN. J Clin Invest. 2024 Feb 1;134(3):e176738. doi: 10.1172/JCI176738. J Clin Invest. 2024. PMID: 38299589 Free PMC article. No abstract available. - Obesity, Dietary Fats, and Gastrointestinal Cancer Risk-Potential Mechanisms Relating to Lipid Metabolism and Inflammation.
Mitchelson KAJ, O'Connell F, O'Sullivan J, Roche HM. Mitchelson KAJ, et al. Metabolites. 2024 Jan 10;14(1):42. doi: 10.3390/metabo14010042. Metabolites. 2024. PMID: 38248845 Free PMC article. Review. - A prospective guide for clinical implementation of selected OGTT- derived surrogate indices for the evaluation of β- cell function and insulin sensitivity in patients with transfusion-dependent β- thalassaemia.
De Sanctis V, Soliman AT, Daar S, Tzoulis P, Karimi M, Saki F, Di Maio S, Kattamis C. De Sanctis V, et al. Acta Biomed. 2023 Dec 5;94(6):e2023221. doi: 10.23750/abm.v94i6.15329. Acta Biomed. 2023. PMID: 38054665 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical